Literature DB >> 20140525

Assessment of clinical practices among cancer genetic counselors.

Deborah Wham1, Thuy Vu, Gayun Chan-Smutko, Christine Kobelka, Diana Urbauer, Brandie Heald.   

Abstract

Various models of cancer genetics service delivery have been published, and practice guidelines were set forth by the National Society of Genetic Counselors (NSGC) in 2004. While the demand for services has increased, there has not been a comprehensive study of current practice models. An online survey of the NSGC Familial Cancer Risk Counseling Special Interest Group was conducted to study current methods of providing clinical cancer genetics services. Respondents were asked to quantify patient volume, support staff availability, and physician involvement in cases. Two case examples were used to further describe current practices including the number of genetic counseling tasks performed, time spent in these tasks, and number of in-person visits versus phone encounters. Although published cancer genetic counseling guidelines advise a 3-visit model (initial consult, sample draw, and result disclosure), 29.3% of respondents have adopted a 1-visit model, where the sample is drawn at the first visit and phone disclosure replaces the third visit. The content of the initial consult does not vary significantly, and is consistent with the NSGC practice guidelines. Furthermore, 56% report spending >15 min on case preparation, and 27 respondents self-reported redundancy in tasks such as documentation. It appears that a proportion of genetic counselors are following a new model of service delivery. However, insufficient documentation and case preparation are apparent, and many respondents reported lack of support staff as a barrier to efficient patient care. Factors contributing to the variability in current practice, and how they affect efficiency, require further study.

Entities:  

Mesh:

Year:  2010        PMID: 20140525     DOI: 10.1007/s10689-010-9326-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  Clinical genetics provider real-time workflow study.

Authors:  Elizabeth McPherson; Christina Zaleski; Katrina Benishek; Catherine A McCarty; Philip F Giampietro; Kara Reynolds; Kristen Rasmussen
Journal:  Genet Med       Date:  2008-09       Impact factor: 8.822

2.  Genetic counseling and clinical cancer genetics services.

Authors:  J E Stopfer
Journal:  Semin Surg Oncol       Date:  2000-06

3.  American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.

Authors:  James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

Review 4.  Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.

Authors:  Angela Trepanier; Mary Ahrens; Wendy McKinnon; June Peters; Jill Stopfer; Sherry Campbell Grumet; Susan Manley; Julie O Culver; Ronald Acton; Joy Larsen-Haidle; Lori Ann Correia; Robin Bennett; Barbara Pettersen; Terri Diamond Ferlita; Josephine Wagner Costalas; Katherine Hunt; Susan Donlon; Cecile Skrzynia; Carolyn Farrell; Faith Callif-Daley; Catherine Walsh Vockley
Journal:  J Genet Couns       Date:  2004-04       Impact factor: 2.537

5.  International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease.

Authors: 
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

6.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

7.  The effectiveness of family history questionnaires in cancer genetic counseling.

Authors:  Susan Randall Armel; Jeanna McCuaig; Amy Finch; Rochelle Demsky; Tony Panzarella; Joan Murphy; Barry Rosen
Journal:  J Genet Couns       Date:  2009-05-21       Impact factor: 2.537

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

9.  The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.

Authors:  Colleen D Murphy; Janie M Lee; Brian Drohan; David M Euhus; Daniel B Kopans; Michele A Gadd; Elizabeth A Rafferty; Michelle C Specht; Barbara L Smith; Kevin S Hughes
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

10.  Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.

Authors:  Jean Jenkins; Kathleen A Calzone; Eileen Dimond; David J Liewehr; Seth M Steinberg; Oxana Jourkiv; Pam Klein; Peter W Soballe; Sheila A Prindiville; Ilan R Kirsch
Journal:  Genet Med       Date:  2007-08       Impact factor: 8.822

View more
  29 in total

1.  From constraints to opportunities? Provision of psychosocial support in portuguese oncogenetic counseling services.

Authors:  Alvaro Mendes; Liliana Sousa; Milena Paneque
Journal:  J Genet Couns       Date:  2013-08-30       Impact factor: 2.537

2.  Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Authors:  Adam H Buchanan; Santanu K Datta; Celette Sugg Skinner; Gail P Hollowell; Henry F Beresford; Thomas Freeland; Benjamin Rogers; John Boling; P Kelly Marcom; Martha B Adams
Journal:  J Genet Couns       Date:  2015-04-03       Impact factor: 2.537

3.  Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.

Authors:  A R Bradbury; L Patrick-Miller; D Fetzer; B Egleston; S A Cummings; A Forman; L Bealin; C Peterson; M Corbman; J O'Connell; M B Daly
Journal:  Clin Genet       Date:  2010-10-12       Impact factor: 4.438

4.  Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.

Authors:  Rosie O'Shea; Marie Meany; Cliona Carroll; Nuala Cody; David Healy; Andrew Green; Sally Ann Lynch
Journal:  J Genet Couns       Date:  2015-09-26       Impact factor: 2.537

5.  Are family-oriented interventions in Portuguese genetics services a remote possibility? Professionals' views on a multifamily intervention for cancer susceptibility families.

Authors:  Alvaro Mendes; Milena Paneque; Liliana Sousa
Journal:  J Community Genet       Date:  2012-02-08

Review 6.  Communicating genetic risk information for common disorders in the era of genomic medicine.

Authors:  Denise M Lautenbach; Kurt D Christensen; Jeffrey A Sparks; Robert C Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2013       Impact factor: 8.929

7.  Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Authors:  C L Scherr; N M Lindor; T L Malo; F J Couch; S T Vadaparampil
Journal:  Clin Genet       Date:  2015-02-26       Impact factor: 4.438

8.  Impact of computer-assisted data collection, evaluation and management on the cancer genetic counselor's time providing patient care.

Authors:  Stephanie A Cohen; Dawn E McIlvried
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

9.  Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.

Authors:  Shubhangi Arora; Eden Haverfield; Gabriele Richard; Susanne B Haga; Rachel Mills
Journal:  J Genet Couns       Date:  2015-08-19       Impact factor: 2.537

10.  Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.

Authors:  Stephanie A Cohen; Monica L Marvin; Bronson D Riley; Hetal S Vig; Julie A Rousseau; Shanna L Gustafson
Journal:  J Genet Couns       Date:  2013-04-25       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.